Eli Lilly offshoot puts biotech vaccine plant on the market
A subsidiary of Eli Lilly, one of the world’s largest pharmaceutical companies, is selling a biotech vaccine manufacturing complex in Sligo for an undisclosed price.
Elanco acquired the facility in the Finisklin Industrial Estate in 2010 and it had an extensive upgrade over the next six years, including a multimillion extension to the manufacturing building in 2012.
It is now being offered for sale through CBRE, the Irish commercial property consultants. John Reynolds, a surveyor...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
The year in review
The best writing and and the biggest stories of 2019 from the Business Post
Newsround: What Thursday’s papers say
Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals
More cycle routes, expansion of Luas to Bray and new bus network proposed
Greater Dublin Area draft Transport Strategy published
